Tag : Meeting

Latest News

Sensorion présente de nouvelles données précliniques sur le SENS-401 à l’ARO MidWinter Meeting 2020

Newsemia
MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN / éligible PEA-PME) société biotechnologique pionnière au stade clinique dédiée au développement de thérapies innovantes pour...
Latest News

CBSET-CILcare to Report Experimental Methodologies for Performing Translational Auditory Research in Pigs and Sheep at the ‘ARO Midwinter Meeting’

Newsemia
LEXINGTON, Mass.–(BUSINESS WIRE)–CBSET-CILcare to report experimental methodologies for performing translational auditory research in pigs and sheep at the ‘ARO Midwinter Meeting’ Source link...
Latest News

Mary Kay Inc. beendet Jahr mit wegweisenden wissenschaftlichen Anerkennungen beim 73. Society of Cosmetic Chemists Meeting

Newsemia
DALLAS–(BUSINESS WIRE)–2019 setzte Mary Kay Inc. sein jahrzehntelanges Engagement in der hautwissenschaftlichen Forschung fort, indem es die Ergebnisse mehrerer bahnbrechender Studien bekannt gab und die...
Latest News

Aurora Bio, Inc Announces Clinical Data on Lead Program, AUR01, a Novel Systemic Amyloidosis Imaging Tracer, at the Upcoming 61st American Society of Hematology Annual Meeting and Exposition

Newsemia
ORLANDO, Fla.–(BUSINESS WIRE)–Aurora Bio, Inc www.Aurorabioinc.com today announced data for the company’s novel PET radiotracer, AUR01, in development for systemic amyloidosis, was presented by Dr....
Latest News

Rocket Pharmaceuticals Presents Promising Preliminary Results from Phase 1 Trial of Commercial-Grade RP-L102 “Process B” for Fanconi Anemia at 61st American Society of Hematology Annual Meeting

Newsemia
NEW YORK–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today...
Latest News

Bristol-Myers Squibb Announces Studies Evaluating liso-cel in Multiple Additional Patient Populations, Site of Care and Disease Areas Presented at American Society of Hematology (ASH) Annual Meeting

Newsemia
PRINCETON, N.J.–(BUSINESS WIRE)—- $BMY–Studies Evaluating Liso-Cel in Multiple Additional Patient Populations, Site of Care and Disease Areas Presented at American Society of Hematology Source link...
Latest News

Syros Presents on Identification of Novel Fetal Hemoglobin Repressor as Part of Broader Drug Discovery Program in Sickle Cell Disease at 61st Annual ASH Meeting

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it has discovered and...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy